{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:05:58Z","timestamp":1789761958641,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.urolonc.2026.07.031","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T12:04:08Z","timestamp":1787400248000},"page":"643-651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of CD103+ tumor-infiltrating lymphocytes in bladder cancer: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7828-1189","authenticated-orcid":false,"given":"Eduardo Germano","family":"Teixeira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Ant\u00f4nio Fernandes","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luiza Rodrigues","family":"Defante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio Medeiros","family":"de Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius Carrera","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.urolonc.2026.07.031_bib0001","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"10.1016\/j.urolonc.2026.07.031_bib0002","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder Cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"10364","key":"10.1016\/j.urolonc.2026.07.031_bib0003","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comp\u00e9rat","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2026.07.031_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01904","article-title":"The emerging role of CD8+ tissue resident memory T (TRM) cells in antitumor immunity: a unique functional contribution of the CD103 integrin","volume":"9","author":"Corgnac","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.031_bib0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s40425-018-0399-6","article-title":"Resident memory T cells, critical components in tumor immunology","volume":"6","author":"Mami-Chouaib","year":"2018","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.031_bib0006","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1038\/s41598-019-40527-4","article-title":"Prognostic significance of CD103+ immune cells in solid tumor: a systemic review and meta-analysis","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.urolonc.2026.07.031_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002231","article-title":"Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade","volume":"9","author":"Banchereau","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"11","key":"10.1016\/j.urolonc.2026.07.031_bib0008","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/s41416-022-01725-6","article-title":"CD103+CD8+ tissue-resident memory T cell infiltration predicts clinical outcome and adjuvant therapeutic benefit in muscle-invasive bladder cancer","volume":"126","author":"Jin","year":"2022","journal-title":"Br J Cancer"},{"issue":"23","key":"10.1016\/j.urolonc.2026.07.031_bib0009","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71429","article-title":"Tissue-resident memory T cells: pioneering new avenues in cancer immunotherapy","volume":"14","author":"Xiao","year":"2025","journal-title":"Cancer Med"},{"key":"10.1016\/j.urolonc.2026.07.031_bib0010","series-title":"Cochrane handbook for systematic reviews of interventions","year":"2019"},{"key":"10.1016\/j.urolonc.2026.07.031_bib0011","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.urolonc.2026.07.031_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"BMJ."},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.031_bib0013","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"issue":"2","key":"10.1016\/j.urolonc.2026.07.031_bib0014","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.juro.2015.02.2941","article-title":"CD103+ Tumor infiltrating lymphocytes predict a favorable prognosis in urothelial cell carcinoma of the bladder","volume":"194","author":"Wang","year":"2015","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.07.031_bib0015","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1245\/s10434-025-17977-4","article-title":"CD103-positive tumor-infiltrating lymphocytes predict a favorable prognosis in colorectal cancer with liver metastasis","volume":"33","author":"Wu","year":"2026","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.07.031_bib0016","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ccell.2021.02.013","article-title":"Progressive immune dysfunction with advancing disease stage in renal cell carcinoma","volume":"39","author":"Braun","year":"2021","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.urolonc.2026.07.031_bib0017","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1158\/2326-6066.CIR-18-0758","article-title":"The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes","volume":"7","author":"Pfannstiel","year":"2019","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.031_bib0018","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40246-021-00308-5","article-title":"High heterogeneity undermines generalization of differential expression results in RNA-Seq analysis","volume":"15","author":"Cui","year":"2021","journal-title":"Hum Genomics"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926006599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926006599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:13:13Z","timestamp":1789758793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926006599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1078143926006599"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.07.031","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of CD103+ tumor-infiltrating lymphocytes in bladder cancer: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}